Controlled drug delivery using magnetoliposomes

• Autorzy: Babincova M. , Babinec P.
• Języki publikacji: EN

Abstrakty

For targeted drug delivery a variety of protector or carrier systems has been developed. One of the promising approaches uses liposomes, which may be partially directed toward particular types of cells by means of antibodies or other ligands. We have proposed recently a new method for drug targeting based on magnetoliposomes, which are liposomes with subdomain magnetite (Fe3O4) particles with a diameter of ≈10 nm incorporated in their bilayers. Due to their magnetic sensitivity a non-homogeneous magnetic field may be used for the targeting of magnetoliposomes to a given tissue. Because magnetite particles are strong microwave absorbers we have experimentally analyzed the influence of microwave radiation with a frequency of 2.45 GHz on the permeability of phosphatidylcholine magnetoliposomes. We have found for example that microwave radiation with specific absorbed power of 400 mW/g almost completely releases entrapped 6-carboxy-fluorescein in 15 min. The probable underlying mechanism is heating of Fe3O4 particles which leads to a perforation of lipid bilayers and subsequent leakage of entrapped magnetoliposome volume, so microwave radiation may be used for controllable release of drugs at low doses of microwave radiation intensities as compared with conventional microwave hyperthermia used previously by other authors.

Słowa kluczowe

EN

liposome; microwave radiation; magnetoliposome; drug delivery system

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 1997
• Tom: 02
• Numer: 1
• Opis fizyczny: p.3-7,fig.

Twórcy

autor

Babincova M.

• Comenius University, MFF UK, Mlynska dolina, 842 15 Bratislava, Slovakia

autor

Babinec P.

Bibliografia

• 1. Fichtner, I. and Arndt, D. Pharmazie 44 (1989) 752-761.
• 2. Gregoriadis, G. and Florence, A.T. Drugs 45 (1993) 15-32.
• 3. Schreier, H. and Bouwstra, J. J. Controll. Release 30 ( 1994) 1-7.
• 4. Ishii, F., Takamura, A. and Ishigami, Y. J. Disper. Sci. Technol. 11 (1990) 581-586.
• 5. Margolis, L.B., Namiot, V.A. and Kljukin, L.M. Biochim. Biophys. Acta 735 (1983) 193-195.
• 6. Babincová, M. Bioelectrochem. Bioenerg. 32 (1993) 187-189.
• 7. Cuyper de, M. and Joniau, M. Biochim. Biophys. Acta 1027 (1990) 172- 178.
• 8. Cuyper de, M. in: Handbook of Nonmedical Applications of Liposomes vol. 3, (Y. Barenholtz and D.D. Lasic, eds.), CRC Press, Boca Raton, 1996, 325-347.
• 9. Kono, H., Hayashi, H. and Takagishi, T. J. Controll. Release 30 (1994) 69-73.
• 10. Saalman, E., Norden, B., Arvidsson, L., Hammerius, Y., Hojevik, P., Connel, K.E. and Kurucsev, T. Biochim. Biophys. Acta 1064 (1991) 124- 129.
• 11. Babincová, M. Z. Naturforsch. 49c (1994) 139-141.
• 12. Babincová, M. Pharmazie 50 (1995) 702-703.
• 13. Babincová, M. Folia Biologica 39 (1993) 250-256.
• 14. Colombo, R., Da Pozzo, L.F. and Rigatti, P. J. Urol. 155 (1996) 1227-1335.
• 15. Kakinuma, K., Tanaka, R. and Kuroki, M. J. Neurosurg. 84 (1996) 180-189.
• 16. Pederzolli, C., Janikowska, S., Di Blas, E., Dalla Sera, M., Cristoforreti, L. and Antolini, R. 3rd W. Mejbaum-Katzenellebogen’s Seminar on Liposomes in Biology and Medicine. Wroclaw/Jamoltòwek, 1996, Abstr. P12.
• 17. Safarik, I., Safarikova, M. and Forsythe, S.J. J. Appl. Bacteriol. 78 (1995) 575-585.
• 18. Babincová, M. and Babinec, P. Pharmazie 50 (1995) 828-829.
• 19. Ringsdorf, H., Schlarb, B. and Venzmer, J. Angew. Chem. 100 (1988) 117-136.
• 20. Riess, J.G. J. Liposome Res. 5 (1995) 413-430.